GLP-1R modulator L7-028

• CAT Number: I045231
• CAS Number: 2648317-95-5
• Molecular Formula: C24H28N2O3
• Molecular Weight: 392.49
• Purity: ≥95%
• Synonyms: 3-cyclopentyloxy-N-[3-(piperidine-1-carbonyl)phenyl]benzamide
• InChI: InChI=1S/C24H28N2O3/c27-23(18-8-7-13-22(17-18)29-21-11-2-3-12-21)25-20-10-6-9-19(16-20)24(28)26-14-4-1-5-15-26/h6-10,13,16-17,21H,1-5,11-12,14-15H2,(H,25,27)
• InChIKey: QASJOTNVPCHDTC-UHFFFAOYSA-N
• SMILES: C1CCN(CC1)C(=O)C2=CC(=CC=C2)NC(=O)C3=CC(=CC=C3)OC4CCCC4

GLP-1R modulator L7-028（Cat No.:I045231）is a small-molecule compound that selectively targets the glucagon-like peptide-1 receptor (GLP-1R), a key regulator of glucose homeostasis and energy balance. By modulating receptor activity, L7-028 enhances insulin secretion in a glucose-dependent manner, suppresses glucagon release, and may slow gastric emptying. This mechanism positions it as a promising candidate for type 2 diabetes and obesity research. Its selective modulation aims to retain therapeutic efficacy while potentially minimizing adverse effects linked to full receptor agonists, offering a valuable tool for metabolic and endocrine disease studies.